Tom Nolan reviews this week’s research The scale and impact of modern health care can be mind-boggling. “Approximately 93 million computed tomography (CT) examinations are performed on 62 million ...

A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] ...

It is the first centre to offer the tech in Melaka and Negeri Sembilan. Malaysia’s Mahkota Medical Centre has announced the ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] ...

Low-dose CT scans are the recommended screening method ... colorectal, lung and prostate cancer deaths between 1975 and 2020. For the study, a team of researchers, led by the University of ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

Metastatic castration-resistant prostate cancer (mCRPC) is diagnosed by blood tests, imaging scans, and biopsies. Find out ...

Illuccix, after radiolabelling with gallium-68, is indicated in France for the detection of prostate-specific membrane ...

CT (Computerized Tomography), also referred to as CAT scan, one of the most valuable discoveries for diagnosis, was invented by British engineer Godfrey Hounsfield in 1967. This life-saving tool ...